Peripheral Blood Mononuclear Cells, Type 2 Diabetes, Frozen
$500
In stock
SKU
Category: Research & Clinical Products
Product Description
Type 2 Diabetes mononuclear cells (MNCs) are separated from peripheral blood by a density gradient centrifugation protocol. MNCs are screened for the expression CD45 and checked for viability using flow cytometry. This highly pure population of cells makes them ideal for further isolations of specific cell types within the mononuclear fraction.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
| Species | Human |
|---|---|
| Disease State | Diseased |
| Cell and Tissue Source | Peripheral Blood |
| Cell Type | Mononuclear Cells |
| Donor Attributes | Inquire |
| Viability | ≥80% by Flow Cytometry |
| Format | Frozen |
| Contains | CryoStor™ CS10 (10% DMSO) |
| Anticoagulant | EDTA |
| Application Area | Research |
Product Information Sheet
Material Safety Data Sheet
Protocols
Customers Also Viewed:
